Into how many milliliters of normal saline (NS) should imipenem be diluted?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Imipenem Dilution Volume

Imipenem should be diluted in 100 mL of normal saline for intravenous infusion 1.

Standard Preparation

The FDA-approved drug label specifies that imipenem/cilastatin powder for injection should be reconstituted and then diluted for administration 1. While the label describes the powder formulation (500 mg/500 mg or 250 mg/250 mg vials), the standard clinical practice involves diluting the reconstituted drug in 100 mL of normal saline for IV infusion.

Alternative Dilution Volume

In certain clinical scenarios, particularly for acute lower gastrointestinal bleeding embolization procedures (an off-label use), imipenem 500 mg/500 mg has been diluted in as little as 5 mL of pure iodine contrast agent to create a particulate suspension 2. However, this is not the standard antimicrobial administration route.

Standard Antimicrobial Administration

For typical antimicrobial therapy:

  • Dilution volume: 100 mL of normal saline
  • Infusion time: 20-60 minutes depending on dose and patient tolerance 1
  • The 20-minute infusion is standard for most doses, though some protocols use longer infusion times (up to 3 hours in pharmacokinetic studies) 3

Important Considerations

  • Chemical stability: Imipenem has limited stability once reconstituted, particularly at room temperature (25°C), with stability of only 2-3 hours in 0.9% NaCl 4
  • Preparation timing: Solutions should be prepared immediately before infusion due to this limited stability
  • Concentration: When diluted in 100 mL, a 500 mg dose yields approximately 5 mg/mL concentration 3

The 100 mL dilution volume provides adequate concentration for effective infusion while maintaining chemical stability during the administration period.

Related Questions

Into how many milliliters of normal saline should a 1‑gram vial of imipenem (imipenem/cilastatin) be diluted?
What is the drop rate per minute for an injectable Dobutamine infusion prepared by adding 250 mg of Dobutamine to 500 mL of 5% dextrose (where 1 mL equals 20 drops) for patients weighing from 5 kg to 80 kg?
What is the proper method to reconstitute and administer dobutamine infusion for an adult patient?
What is the dose chart and drop rate per minute for a dobutamine infusion prepared by adding 250 mg to 500 mL of 5 % dextrose, for patients weighing 10 kg to 80 kg, assuming 1 mL equals 20 drops?
What is the proper preparation method for dobutamine infusion?
What over‑the‑counter treatment options are available for oral and vaginal candidiasis (thrush) in adults, including during pregnancy?
In a 17-year-old male with normal serum creatinine and a first-morning urine protein of 30 mg/dL and urine creatinine of 239.4 mg/dL, what is the significance of this proteinuria and how should it be managed?
How should skin sensitivity be evaluated and managed in a patient taking a GLP‑1 receptor agonist (e.g., exenatide, liraglutide, semaglutide, dulaglutide, tirzepatide)?
How should functional capacity be assessed for pre‑surgical clearance, and what MET threshold indicates sufficient reserve to proceed?
What is the recommended dosing and administration of imipenem‑cilastatin 1 g for a severe infection in an adult with normal renal function?
Into how many milliliters of normal saline should a 1‑gram vial of imipenem (imipenem/cilastatin) be diluted?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.